External resources FDA information on semaglutide medications for diabetes and obesity SURMOUNT-1 tirzepatide trial in the New England Journal of Medicine For those serious about optimizing their GLP-1 journey, SeekPeptides offers comprehensive protocols, dosing tools, tracking resources, and a community of thousands who have navigated these exact questions
In addition to the incretin effects, GLP-1 promotes satiety 11 and GIP promotes lipid storage and metabolic regulation 12,13,14,15
noncompliance with self-monitoring of blood glucose concentrations
Medical nutrition therapy interventions provided by dietitians for adult overweight and obesity management: an Academy of Nutrition and Dietetics evidence-based practice guideline
The most commonly reported adverse effects in the trial were gastrointestinal in nature including nausea, diarrhoea, vomiting, and constipation which is consistent with the broader GLP-1 receptor agonist class
Always consult with a qualified healthcare professional before starting any new medication or treatment and before changing your diet or supplement regimen.
